AVAHAveanna Healthcare Holdings, Inc.(AVAH)Stock Analysis

AI analysis on 2,800+ stocks →
HealthcareNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1832332AVAH stock profile & AI dashboard →

13F Pro Quality Score

59.2/100

Rank #935 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

70.8/100

Profitability

64.1/100

Balance Sheet

66.8/100

Earnings Quality

30.0/100

Free Cash Flow

45.5/100

Institutional Flow

24.6/100

Revenue Scale

65.6/100

Dilution Risk

56.5/100

AVAH Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Aveanna Healthcare Holdings, Inc. (AVAH), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AVAH at 59.2/100 on a 32-signal composite quality model, placing it at rank #935 of 2,879 stocks — the top half of the AI-ranked universe. Areas of concern include institutional flow (24.6) and earnings quality (30.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Aveanna Healthcare Holdings, Inc. reports quarterly revenue of $647.9M, net income of $41.7M, an operating margin of 10.7%. Top institutional holders of AVAH by reported 13-F value include BAIN CAPITAL INVESTORS, J.H. Whitney Equity Partners VII,, Nut Tree Capital Management,, based on the most recent SEC filings. AVAH trades on the Nasdaq exchange and files with the SEC under CIK 1832332. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVAH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Aveanna Healthcare Holdings, Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$647.9M

Net Income

Q1 2026

$41.7M

Free Cash Flow

Q1 2026

$4.3M

Operating Margin

Q1 2026

10.7%

Get alerted when AVAH's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Aveanna Healthcare Holdings, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of AVAH

Put AVAH on your watchlist

Track score changes the day Aveanna Healthcare Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is AVAH a good stock to buy?

13F Pro's AI-powered analysis of Aveanna Healthcare Holdings, Inc. (AVAH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AVAH are available on the AVAH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own AVAH?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AVAH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Aveanna Healthcare Holdings, Inc.'s investment landscape.